BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2014 4:58:00 PM | Browse: 1070 | Download: 800
 |
Received |
|
2012-08-21 14:22 |
 |
Peer-Review Started |
|
2012-09-18 13:39 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2012-10-10 10:10 |
 |
Revised |
|
2012-10-10 17:48 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2012-10-30 09:28 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2012-10-30 13:14 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-01-29 17:47 |
 |
Publish the Manuscript Online |
|
2013-01-30 19:41 |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Field of Vision |
| Article Title |
Transglutaminase inhibition: A therapy to protect cells from death in neurodegeneration?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Martina Iannaccone, Alessandro Stefanile, Giulia De Vivo, Antonio Martin, Enrica Serretiello and Vittorio Gentile |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Vittorio Gentile, MD, PhD, Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Via Costantinopoli 16, 80138 Naples, Italy. vittorio.gentile@unina2.it |
| Key Words |
Transglutaminases; Post-translational modifications of proteins; Neurological diseases; Transglutaminase inhibitors; Neuronal death |
| Core Tip |
|
| Publish Date |
2013-01-30 19:41 |
| Citation |
Iannaccone M, Stefanile A, De Vivo G, Martin A, Serretiello E, Gentile V. Transglutaminase inhibition: A therapy to protect cells from death in neurodegeneration? World J Biol Chem 2012; 3(11): 184-186 |
| URL |
http://www.wjgnet.com/1949-8454/full/v3/i11/184.htm |
| DOI |
http://dx.doi.org/10.4331/wjbc.v3.i11.184 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.